Congress' final agreement on a fiscal year 2017 appropriations boosts funding for a few science agencies while holding others steady.
S. 442: National Aeronautics and Space Administration Transition Authorization Act of 2017 The federal budget process occurs in two stages: appropriations and authorizations. This is an authorization bill, which direct how federal funds should or should not be used. Appropriations set overall spending limits by agency or program and are typically made for single fiscal years … Continue reading NASA Transition Authorization Act Allocates $19.508 Billion for 2017
Tom Price was Senate-confirmed as secretary of health and human services on a party-line 52–47 vote on February 10, 2017. He will have responsibility over the National Institutes of Health and the Centers for Disease Control, among a number of other research and public health agencies.
President Donald Trump has decided to retain Dr. Francis Collins as director of the US National Institutes of Health (NIH) until a permanent Director is appointed. The hold-over of Collins will provide some consistency to the agency during the uncertain budget period looming in 2017.
Federal science agencies in general will be barred from starting new programs or stopping old ones and from implementing funding increases submitted in the president’s fiscal year 2017 budget request.
Both the House and Senate have passed the fiscal year 2017 “National Defense Authorization Act." The NDAA is a bill, passed annually, that authorizes and sets policy for defense programs at the Defense and Energy Departments, including defense R&D.
21st Century Cures Act PASSES Senate 94-5 . More than $192 million in lobbying expenses have been spent on the 21st Century Cures Act and other legislative priorities by 58 pharmaceutical companies, 24 device companies and 26 biotech companies, according to a Kaiser Health News analysis of lobbying data compiled by the Center for Responsive Politics.